 |
|
 |
- March 11, 2010 |
|
 |
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
 |
| Presentation |
|
"Diabetes/Lipids"Dr. Lawrence A. Leiter (biography)
English - 2003-08-10 - 85 minutes
|
 | (64 slides) |
Summary :
In this era of evidence-based medicine we have been lucky to have several ongoing studies in diabetes that touch on many levels. We are learning more about the risk factors predisposing to CVD and other complications, and diabetes prevention is now also a major research focus. Several lipid-lowering studies have been conducted to date, and this presentation will provide new information gleaned from these studies as well as new information on the therapeutic effects of drugs like statins and others.
Learning objectives :
The participant will review the results of several major lipid-lowering studies and get an update on the new drugs available like some statins and others, and how these drugs work and how they may be used.
Bibliographic references :
Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J. Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators. J Hypertens. 2001 Jun;19(6):1139-47.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi
Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003 Apr 5;361(9364):1149-58.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi
|
|
|
|
|
 |

| Search our website |
 |
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|

| Social |
 |
| |
Let others know about this presentation.
|
|

|
|